联合检测血清铁蛋白和甲胎蛋白在原发性肝癌患者中应用效果的研究  

Effect of combined detection of serum ferritin and alpha-fetoprotein in patients with primary liver cancer

作　　者：熊晏[1] 龙黎 张卿 罗燕[1] 车盈辰 Xiong Yan;Long Li;Zhang Qing;Luo Yan;Che Yingchen(Department of Infectious Diseases,Guizhou Provincial People’s Hospital,Guiyang 550003,Guizhou,China;Guizhou Provincial Health Academic Promotion Center,Guiyang 550004,Guizhou,China)

机构地区：[1]贵州省人民医院感染科,贵阳贵州550003 [2]贵州省卫生健康学术促进中心,贵州贵阳550004

出　　处：《贵州医药》2024年第8期1195-1197,共3页Guizhou Medical Journal

摘　　要：目的研究检测原发性肝癌患者血清铁蛋白和甲胎蛋白获得的临床效果。方法选取2022年1-12月就诊144例原发性肝癌患者,将其作为研究对象进行组别划分。其中144例原发性肝癌患者为研究组,100名正常人员为对照组,比较两组的甲胎蛋白(AFP)和血清铁蛋白(SF)测定结果、AFP和SF阳性率。结果研究组的血清AFP和SF测定结果较对照组明显,且与对照组的AFP和SF阳性率比较,研究组数值更高(P<0.05)。结论经血清铁蛋白和甲胎蛋白联合检测原发性肝癌,发现实际诊断价值较高,能发挥良好的应用效果。Objective To analyze the clinical diagnostic and therapeutic effects of serum ferritin and alpha-fetoprotein detection in patients with primary liver cancer.Methods From January 2022 to December 2022,144 patients diagnosed with primary liver cancer were enrolled as the study subjects and were divided into groups.Among them,144 cases of primary liver cancer patients comprised the study group,while 100 normal individuals formed the control group.The serum levels of AFP and SF,as well as the positivity rates of AFP and SF,were compared between the two groups.Results The serum AFP and SF detection results in the study group were significantly higher than those in the control group.Moreover,when compared to the control group,the study group exhibited higher AFP and SF positivity rates.The intergroup there were statistically significant differences(P<0.05).Conclusion Combined detection of serum ferritin and alpha-fetoprotein in primary liver cancer demonstrates a higher practical diagnostic value,showing promising utility in clinical applications.

关 键 词：血清铁蛋白 甲胎蛋白 原发性肝癌 

分 类 号：R735.7[医药卫生—肿瘤]